Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10501
Invesco Dorsey Wright Technology Momentum ETF
PTF
$628M
| $190K | ﹤0.01% |
2,617
-3,925
| -60% | -$278K |
2024 Q3
1 quarter
|
|
10502
CALL
Victory Capital Holdings
VCTR
$6.87B
| $190K | ﹤0.01% |
2,900
-3,200
| -52% | -$203K |
2022 Q4
8 quarters
|
|
10503
CALL
VanEck Pharmaceutical ETF
PPH
$1.03B
| $190K | ﹤0.01% |
2,200
+1,200
| +120% | +$109K |
2022 Q2
10 quarters
|
|
10504
CALL
Home BancShares
HOMB
$5.7B
| $190K | ﹤0.01% |
6,700
-1,800
| -21% | -$52K |
2022 Q4
8 quarters
|
|
|
NTRBW
10505
DELISTED
Nutriband Inc Warrant
NTRBW
| $190K | ﹤0.01% |
126,392
+9,801
| +8% | +$14.5K |
2023 Q2
6 quarters
|
|
10506
Westwood Holdings Group
WHG
$183M
| $189K | ﹤0.01% |
+13,048
| New | +$200K |
2024 Q4
0 quarters
|
|
10507
Pembina Pipeline
PBA
$27.4B
| $189K | ﹤0.01% |
5,122
-258,416
| -98% | -$10.5M |
2021 Q4
12 quarters
|
|
10508
Arcos Dorados Holdings
ARCO
$1.71B
| $189K | ﹤0.01% |
25,987
+21,028
| +424% | +$180K |
2022 Q1
11 quarters
|
|
10509
CALL
Bioceres Crop Solutions
BIOX
$20.9M
| $189K | ﹤0.01% |
31,100
+30,700
| +7,675% | +$210K |
2024 Q3
1 quarter
|
|
10510
PUT
NovaGold Resources
NG
$2.76B
| $189K | ﹤0.01% |
56,700
+24,900
| +78% | +$88K |
2013 Q2
46 quarters
|
|
|
BRKL
10511
DELISTED
Brookline Bancorp
BRKL
| $189K | ﹤0.01% |
15,997
-248,290
| -94% | -$2.88M |
2013 Q2
46 quarters
|
|
10512
InterGroup Corp
INTG
$69.4M
| $189K | ﹤0.01% |
13,480
-2,545
| -16% | -$36.8K |
2024 Q2
2 quarters
|
|
10513
CALL
Littelfuse
LFUS
$10.8B
| $189K | ﹤0.01% |
800
+100
| +14% | +$24.9K |
2020 Q4
16 quarters
|
|
10514
CALL
Vita Coco
COCO
$3.24B
| $188K | ﹤0.01% |
5,100
+4,300
| +538% | +$143K |
2021 Q4
12 quarters
|
|
10515
CALL
Vanguard Long-Term Treasury ETF
VGLT
$10B
| $188K | ﹤0.01% |
3,400
-8,200
| -71% | -$475K |
2021 Q1
15 quarters
|
|
10516
CALL
ANI Pharmaceuticals
ANIP
$1.65B
| $188K | ﹤0.01% |
3,400
-8,300
| -71% | -$477K |
2022 Q4
8 quarters
|
|
|
FNUC
10517
CALL
Frontier Nuclear and Minerals Inc
FNUC
$40.2M
| $188K | ﹤0.01% |
15,054
+10,154
| +207% | +$43.3K |
2024 Q3
1 quarter
|
|
10518
Star Group
SGU
$426M
| $188K | ﹤0.01% |
16,266
-46,601
| -74% | -$548K |
2023 Q4
4 quarters
|
|
10519
PUT
TD Synnex
SNX
$21.3B
| $188K | ﹤0.01% |
1,600
-18,200
| -92% | -$2.18M |
2016 Q4
32 quarters
|
|
10520
CALL
REX American Resources
REX
$1.49B
| $188K | ﹤0.01% |
9,000
-13,800
| -61% | -$305K |
2022 Q4
8 quarters
|
|
10521
PUT
MeiraGTx Holdings
MGTX
$1.01B
| $188K | ﹤0.01% |
30,800
-200
| -0.6% | -$1.17K |
2022 Q3
9 quarters
|
|
|
TALK
10522
CALL
DELISTED
Talkspace
TALK
| $188K | ﹤0.01% |
60,700
+10,600
| +21% | +$32.2K |
2024 Q1
3 quarters
|
|
|
RPT
10523
Rithm Property Trust
RPT
$84.2M
| $187K | ﹤0.01% |
10,518
+6,556
| +165% | +$121K |
2022 Q4
8 quarters
|
|
|
BYAH
10524
Park Ha Biological Technology Co
BYAH
$1.97M
| $187K | ﹤0.01% |
+74
| New | +$150K |
2024 Q4
0 quarters
|
|
10525
CALL
Selective Insurance
SIGI
$5.07B
| $187K | ﹤0.01% |
2,000
-700
| -26% | -$67.1K |
2022 Q3
9 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.